{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01051",
      "entity_text" : "rmMFG-E8",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "In the present study, NF-kappaB activation was found in the CLP group, and rmMFG-E8 treatment inhibited NF-kappaB activation, indicating that inhibiting NF-kappaB disrupts the production of inflammatory cytokines and mediators.",
  "reading_complete" : "2020-08-05T19:50:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:50:03Z",
  "trigger" : "inhibited",
  "evidence" : [ "rmMFG-E8 treatment inhibited NF-kappaB" ],
  "pmc_id" : "6585916",
  "score" : 0
}